Clinical Trial Patient Matching: A Real-Time, Common Data Model and Artificial Intelligence–Driven System for Semiautomated Patient Prescreening in Cancer Clinical Trials
JCO Clinical Cancer Informatics · 2026-01 · 10 (1)
DOI: 10.1200/cci-25-00262 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Clinical Cancer Informatics, 2026-01. Verfasst von Guannan Gong und 27 weiteren Autor:innen. Beteiligte Einrichtung: Yale Cancer Center, Yale School of Medicine, New Haven, CT. Hauptthemen laut MEDLINE: Artificial Intelligence, Clinical Trials as Topic, Patient Selection, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
PURPOSE Cancer clinical trial enrollment remains critically low at 5%-7% of adult patients despite exponential growth in available trials. Manual patient-trial matching represents a fundamental bottleneck, whereas current artificial intelligence (AI) and machine learning patient-trial matching systems lack data standardization and compatibility across health systems. We developed and validated a semiautomated clinical trial patient matching (CTPM) tool to improve recruitment efficiency and scalability. METHODS We created a hybrid rules–based and natural language processing (NLP)–based pipeline that automatically screens patients using structured and unstructured electronic health record data standardized to the Observational Medical Outcomes Partnership (OMOP) common data model. CTPM performance was first evaluated on one metastatic colorectal cancer (CRC) trial by comparing CTPM accuracy and efficiency to manual chart review. Following the single-trial validation, we then implemented the system across 29 clinical trials spanning multiple cancer specialties and phases. RESULTS For the single CRC trial, CTPM achieved 94% retrospective and 88% prospective accuracy, matching gold standard clinical chart review with 100% sensitivity. Implementation reduced chart review workload 10-fold and screening time by 41% (3.1 to 1.8 minutes per chart) for those patients who did undergo review. Since September 2022, the system has screened 98,348 patients across 29 trials, identifying 825 eligible candidates and facilitating 117 patient enrollments with 9%-37% consent rates. CONCLUSION This AI and NLP tool demonstrates improved efficiency in clinical trial recruitment by enabling research teams to focus on qualified candidates rather than exhaustive chart reviews. The OMOP-based framework supports scalability across health systems, with potential to address enrollment challenges that limit patient access to clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Yale Cancer Center, Yale School of Medicine, New Haven, CT.
- Department of Medicine, Division of Medical Oncology, Yale School of Medicine, New Haven, CT.
- Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT.
- Digital and Technology Solutions, Yale New Haven Hospital, New Haven, CT.
- Department of Medicine, Division of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT.
- Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT.
ORCID-Profile: Guannan Gong, Jessica Liu, Sameer Pandya, Cristian Taborda, Nate Price, Andreas Coppi, Patrick Young, Neal Fischbach, Lajos Pusztai, Mariya Rozenblit, Michael Cecchini, Anne Mongiu, Lourdes Mendez, Harlan Krumholz, Ian Krop, Wade Schulz, Maryam Lustberg, Pamela L Kunz
Zitieren
APA
Gong, G., Liu, J., Pandya, S., Taborda, C., Wiesendanger, N., Price, N., Byron, W., Coppi, A., Young, P., Wiess, C., Dunning, H., Barganier, C., Brodeur, R., Fischbach, N., LoRusso, P., Pusztai, L., Kim, S. Y., Rozenblit, M., Cecchini, M., …, & Kunz, P. L. (2026). Clinical Trial Patient Matching: A Real-Time, Common Data Model and Artificial Intelligence–Driven System for Semiautomated Patient Prescreening in Cancer Clinical Trials. JCO Clinical Cancer Informatics, 10(1). https://doi.org/10.1200/cci-25-00262
Vancouver
Gong G, Liu J, Pandya S, Taborda C, Wiesendanger N, Price N, et al. Clinical Trial Patient Matching: A Real-Time, Common Data Model and Artificial Intelligence–Driven System for Semiautomated Patient Prescreening in Cancer Clinical Trials. JCO Clinical Cancer Informatics. 2026;10(1). doi:10.1200/cci-25-00262
BibTeX
@article{Gong2026,
author = {Gong, Guannan and Liu, Jessica and Pandya, Sameer and Taborda, Cristian and Wiesendanger, Nathalie and Price, Nate and Byron, Will and Coppi, Andreas and Young, Patrick and Wiess, Christina and Dunning, Haley and Barganier, Courtney and Brodeur, Rachel and Fischbach, Neal and LoRusso, Patricia and Pusztai, Lajos and Kim, So Yeon and Rozenblit, Mariya and Cecchini, Michael and Mongiu, Anne and Mendez, Lourdes and Kaftan, Edward and Torre, Charles and Krumholz, Harlan and Krop, Ian and Schulz, Wade and Lustberg, Maryam and Kunz, Pamela L},
title = {Clinical Trial Patient Matching: A Real-Time, Common Data Model and Artificial Intelligence–Driven System for Semiautomated Patient Prescreening in Cancer Clinical Trials},
journal = {JCO Clinical Cancer Informatics},
year = {2026},
volume = {10},
number = {1},
doi = {10.1200/cci-25-00262}
}
EUVIMED